
C4 Therapeutics Inc (CCCC) poses a Brand-New Opportunity for Investors with beta value of 2.94
As on Wednesday, C4 Therapeutics Inc (NASDAQ: CCCC) started slowly as it slid -3.36% to $1.44, before settling in for the price of $1.49 at
As on Wednesday, C4 Therapeutics Inc (NASDAQ: CCCC) started slowly as it slid -3.36% to $1.44, before settling in for the price of $1.49 at
C4 Therapeutics Inc (NASDAQ: CCCC) open the trading on Wednesday, with great promise as it jumped 4.05% to $1.54, before settling in for the price
C4 Therapeutics Inc (NASDAQ: CCCC) flaunted slowness of -3.08% at $1.26, as the Stock market unbolted on Wednesday, before settling in for the price of
On Friday, C4 Therapeutics Inc (NASDAQ: CCCC) was 0.73% up from the session before settling in for the closing price of $1.37. A 52-week range
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.